Literature DB >> 2153225

Avian reticuloendotheliosis virus-transformed lymphoid cells contain multiple pp59v-rel complexes.

N Davis1, W Bargmann, M Y Lim, H Bose.   

Abstract

The v-rel oncogene of avian reticuloendotheliosis virus type T (REV-T) encodes a 59-kilodalton (kDa) phosphoprotein located principally in the cytosol of transformed lymphoid cells. All of the detectable pp59v-rel was present in high-molecular-weight complexes containing at least five cellular proteins (p124, p115, p75c-rel, p70hsc, and pp40). Antiserum was developed against the 40-kDa protein, the most abundant cellular protein associated with the complex. The 40-kDa phosphoprotein was complexed with pp59v-rel in REV-T-transformed lymphoid cell lines arrested at different stages of B-cell development as well as in lymphoid tumor cells and in fibrosarcomas. The half-life (8 h) of pp40 in REV-T-transformed lymphoid cells was the same as that of pp59v-rel. Antiserum against pp40 permitted the identification of two pp59v-rel complexes. The most abundant cytoplasmic complex contained approximately 75% of the pp59v-rel and all of the detectable pp40 in REV-T-transformed lymphoid cells. Twenty-five percent of the pp59v-rel was present in a minor complex that contained the majority of p75c-rel along with p115 and p124. In nuclear extracts of REV-T-transformed lymphoid cells, pp59v-rel was complexed with pp40. The two high-molecular-weight proteins (p115 and p124) and p75c-rel were not detected in the nuclear complex. In the cytosolic complexes, pp40 was heavily phosphorylated, whereas the nuclear form was much less extensively phosphorylated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153225      PMCID: PMC249147     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  The transforming protein of avian reticuloendotheliosis virus is a soluble cytoplasmic protein which is associated with a protein kinase activity.

Authors:  D S Walro; N K Herzog; J Zhang; M Y Lim; H R Bose
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

2.  Expression of the v-rel oncogene in reticuloendotheliosis virus-transformed fibroblasts.

Authors:  B E Moore; H R Bose
Journal:  Virology       Date:  1988-02       Impact factor: 3.616

Review 3.  Unraveling of mitotic control mechanisms.

Authors:  W G Dunphy; J W Newport
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

4.  The v-rel oncogene product is complexed to a 40-kDa phosphoprotein in transformed lymphoid cells.

Authors:  H Y Tung; W J Bargmann; M Y Lim; H R Bose
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Control of the yeast cell cycle is associated with assembly/disassembly of the Cdc28 protein kinase complex.

Authors:  C Wittenberg; S I Reed
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

6.  p59v-rel, the transforming protein of reticuloendotheliosis virus, is complexed with at least four other proteins in transformed chicken lymphoid cells.

Authors:  S Simek; N R Rice
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF.

Authors:  D Arion; L Meijer; L Brizuela; D Beach
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

8.  Genome of reticuloendotheliosis virus: characterization by use of cloned proviral DNA.

Authors:  N R Rice; R R Hiebsch; M A Gonda; H R Bose; R V Gilden
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

9.  Identification of p34 and p13, human homologs of the cell cycle regulators of fission yeast encoded by cdc2+ and suc1+.

Authors:  G Draetta; L Brizuela; J Potashkin; D Beach
Journal:  Cell       Date:  1987-07-17       Impact factor: 41.582

10.  Purified maturation-promoting factor contains the product of a Xenopus homolog of the fission yeast cell cycle control gene cdc2+.

Authors:  J Gautier; C Norbury; M Lohka; P Nurse; J Maller
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

View more
  34 in total

1.  Mutational analysis of the v-Rel dimerization interface reveals a critical role for v-Rel homodimers in transformation.

Authors:  Andrew S Liss; Henry R Bose
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  c-rel activates but v-rel suppresses transcription from kappa B sites.

Authors:  J Inoue; L D Kerr; L J Ransone; E Bengal; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein.

Authors:  S Kumar; A B Rabson; C Gélinas
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

4.  vRel is an inactive member of the Rel family of transcriptional activating proteins.

Authors:  P M Richardson; T D Gilmore
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Loss of IkappaB alpha-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel.

Authors:  S Sachdev; M Hannink
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

6.  Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.

Authors:  D W White; G A Pitoc; T D Gilmore
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

7.  Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors.

Authors:  A Rebollo; L Dumoutier; J C Renauld; A Zaballos; V Ayllón; C Martínez-A
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

8.  Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex.

Authors:  M Tewari; P Dobrzanski; K L Mohn; D E Cressman; J C Hsu; R Bravo; R Taub
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

9.  Alternative splicing of RNA transcripts encoded by the murine p105 NF-kappa B gene generates I kappa B gamma isoforms with different inhibitory activities.

Authors:  R J Grumont; S Gerondakis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

10.  Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha.

Authors:  K Brown; S Park; T Kanno; G Franzoso; U Siebenlist
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.